MentionFox
Home › Who owns › Transcode Therapeutics, Inc.
Owners, funding and legal record

Who owns Transcode Therapeutics, Inc.? Owners, funding and legal record

The most recent 5%+ ownership report on Transcode Therapeutics, Inc. names Ck Life Sciences Int'L., (Holdings) Inc. holding 83.9% (Schedule 13D/A, filed 2026-08-03).

About to sign with, pay or invest in Transcode Therapeutics, Inc.? See the free Snapshot first.

Free to see. No signup.

Before you sign or pay

Who is behind it

Transcode Therapeutics, Inc.: incorporated in Delaware; business address in Boston, Massachusetts; industry Pharmaceutical Preparations (Schedule 13D/A, 2026-08-03).

Officers and directors, each with the role and the filing that names them:

ReportHolderShare
Schedule 13D/A, 2026-08-03Ck Life Sciences Int'L., (Holdings) Inc.83.9%
Schedule 13G, 2026-07-28Elena Rosa Braci6.17%
Schedule 13G, 2026-07-28Daniel Eduardo Katzman5.16%
Schedule 13G, 2026-07-28Unleash Immuno Oncolytics, Inc.9.94%
Schedule 13D/A, 2026-07-27Ck Life Sciences Int'L., (Holdings) Inc.83.9%
Schedule 13D/A, 2026-07-23Ck Life Sciences Int'L., (Holdings) Inc.9.9%
Schedule 13D/A, 2026-07-17Ck Life Sciences Int'L., (Holdings) Inc.8.8%
Schedule 13G, 2026-04-20Ya Ii Pn, LTD.9.9%

Money raised

FiledSoldOffered
Form D, 2024-12-12$8M$8M

Latest IPO step: Transcode Therapeutics, Inc. filed to go public (S-1, 2026-05-01).

IPO filings: S-1, 2026-05-01, S-1, 2024-12-06; ticker RNAZ on Nasdaq Capital Market.

Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2025-10-08).

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/transcode-therapeutics
Last updated 2026-10-18
Who owns Transcode Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/transcode-therapeutics